The effects of cinnarizine versus sodium valproate in migraine prophylaxis

International Journal of Neuroscience

Volumn 123, Issue 7, 2013, Pages 487-493

  Bostani, Arash ^a   Rajabi, Aref ^a   Moradian, Nasrin ^a   Razazian, Nazanin ^a   Rezaei, Mansour ^b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cinnarizine; Migraine prophylaxis; Sodium valproate

Indexed keywords

CINNARIZINE; ERGOTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TRIPTAN DERIVATIVE; VALPROIC ACID;

ADULT; AGED; ARTICLE; ATTENTION DISTURBANCE; CONSTIPATION; CONTROLLED STUDY; DECREASED APPETITE; DISEASE ASSOCIATION; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EYE PAIN; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HAIR LOSS; HEADACHE; HUMAN; INCREASED APPETITE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDAS (MIGRAINE); MIGRAINE; NAUSEA; PAIN ASSESSMENT; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TASTE DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; VERTIGO; VISUAL ACUITY; VOMITING; WEIGHT GAIN; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CALCIUM CHANNEL BLOCKERS; CINNARIZINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; VALPROIC ACID;

EID: 84879127457     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.765419     Document Type: Article

References (30)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002;346:257- 70
2. Hamalainen ML.Migraine in children and adolescents: A guide to drug treatment. CNS Drugs 2006;20:813-20
3. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9.
4. Buchanan TM, Ramadan NM. Prophylactic pharmacotherapy for migraine headaches. Semin Neurol 2006;26:188-98
5. Diener HC, Limmroth V. Migraine therapy. Internist (Berl) 2005;46:1087-95
6. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol 1995;52:281-6.
7. Klapper J. Divalproex sodium in migraine prophylaxis: A dose controlled study. Cephalalgia 1997;17:103-8.
8. Mathew NT, Rapoport A, Saper J. Efficacy of gabapentin in migraine prophylaxis. Headache 2001;41:119-28
9. Freitag FG, Collins SD, Carlson HA. A randomized trial of divalproex sodium extended release tablets in migraine prophylaxis. Neurology 2002;58:1652-9.
10. Togha M, Ashrafian H, Tajik P. Open-label trial of cinnarizine in migraine prophylaxis. Headache 2006;46:498-502
11. Rossi P, Fiermonte G, Pierelli F. Cinnarizine in migraine prophylaxis: Efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial. Funct Neurol 2003;18:155-9.
12. The International Headache Society Committee on Clinical Trials on Migraine. Guidelines for controlled trials of drugs in migraine, 1st edn. Cephalalgia 1991;11:1-12
13. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988;8(Suppl 7):1-96
14. Amelin AV, Skoromets AA, Gonchar MA, et al. Comparative efficacy of betaserc and cinnarizine in vertigo in patients with migraine. Zh Neurol Psikhiatr Im S S Korsakova 2003;103: 43-8.
15. Togha M, Rahmat Jirde M, Nilavari K, et al. Cinnarizine in refractory migraine prophylaxis: Efficacy and tolerability. A comparison with sodium valproate. J Headache Pain 2008;9:77-82
16. Punay NC, Couch Jr. Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 2003;7:51-4.
17. Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: A double-blind, placebo-controlled study. Headache 2001;41:968-75
18. Rapoport A, Mauskop A,DienerHC, et al. Long-termmigraine prevention with topiramate: open-label extension of pivotal trials. Headache 2006;46:1151-60
19. Dariush A, Shabnam R, Mansour R. A Comparative Study of the Effects of Low-Dose Topiramate Versus Sodium Valproate in Migraine Prophylaxis. International journal of Neuroscience 2012 Feb;122(2):60-68
20. Erdemoglu AK, Ozbakir S. Valproic acid in prophylaxis of refractory migraine. Acta Neurol Scand 2000;102:354-358
21. The International Classification of Headache Disorders. 2nd ed. Headache Classification Subcommittee of the International Headache Society. Cephalagia (Oxford, England, UK: Blackwell Publishing) 2004;24(1):1-160
22. Bassi P, Brunati L, Rapuzzi B, et al. Low dose flunarizine in the prophylaxis of migraine. Headache 1992;32:390-2.
23. Macedo A, Banos JE, FarreM. Placebo response in the prophylaxis of migraine: A meta-Analysis. Eur J Pain 2008;12:68-75
24. Freitag FG, Collins SD, Carlson BA, Goldstein BA. A randomized trial of divalproex sodium extended - release tablets in migraine prophylaxis. Neurology 2002;58:1652-9.
25. Mathew NT, Saper JR, Silberstain SD, et al. Migraine prophylaxis with divalproex. Arch Neurol 1995;52:281-6.
26. Klapper J. Divalproex sodium in migraine prophylaxis: A dosecontrolled study. Cephalalgia 1997;17:103-8.
27. Mathew NT, Rapoport A, Saper J, et al. Efficacy of gabapentin in migraine prophylaxis. Headache 2001;41:119-28
28. Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: A double-blind study versus placebo. Cephalalgia 1992;12:81-4.
29. Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: An open clinical trial. Cephalalgia 1989;9:195-8.
30. Shaygannejad V, Janghorbani M, Ghorbani A, et al. Comparison of the effect of topiramate and sodium valproate in migraine prevention: A randomized blinded cross over study. Headache 2006;46:642-8.